574 related articles for article (PubMed ID: 26709085)
1. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
[TBL] [Abstract][Full Text] [Related]
3. Where have all the trisomies gone?
Palomaki GE; Lambert-Messerlian GM; Haddow JE
Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793310
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
5. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
6. Women should decide which conditions matter.
Norton ME; Kuppermann M
Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793311
[TBL] [Abstract][Full Text] [Related]
7. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
Yankova M; Chaveeva P; Stratieva V
Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
[TBL] [Abstract][Full Text] [Related]
8. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
9. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
11. What would be missed in the first trimester if nuchal translucency measurement is replaced by cell free DNA foetal aneuploidy screening?
Huang LY; Pan M; Han J; Zhen L; Yang X; Li DZ
J Obstet Gynaecol; 2018 May; 38(4):498-501. PubMed ID: 29433355
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA analysis for noninvasive examination of trisomy.
Norton ME; Jacobsson B; Swamy GK; Laurent LC; Ranzini AC; Brar H; Tomlinson MW; Pereira L; Spitz JL; Hollemon D; Cuckle H; Musci TJ; Wapner RJ
N Engl J Med; 2015 Apr; 372(17):1589-97. PubMed ID: 25830321
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis.
Gil MM; Akolekar R; Quezada MS; Bregant B; Nicolaides KH
Fetal Diagn Ther; 2014; 35(3):156-73. PubMed ID: 24513694
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center.
Shani H; Goldwaser T; Keating J; Klugman S
Am J Obstet Gynecol; 2016 Jun; 214(6):729.e1-729.e11. PubMed ID: 26721783
[TBL] [Abstract][Full Text] [Related]
16. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
17. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
[TBL] [Abstract][Full Text] [Related]
18. First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
Kagan KO; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):42-7. PubMed ID: 25307357
[TBL] [Abstract][Full Text] [Related]
19. Detection of fetal subchromosomal aberration with cell-free DNA screening led to diagnosis of parental translocation: Review of 11344 consecutive cases in a university hospital.
Qian YQ; Wang XQ; Chen M; Luo YQ; Yan K; Yang YM; Liu B; Wang LY; Huang YZ; Li HG; Pan HY; Jin F; Dong MY
Eur J Med Genet; 2019 Feb; 62(2):115-123. PubMed ID: 29929010
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide detection of additional fetal chromosomal abnormalities by cell-free DNA testing of 15,626 consecutive pregnant women.
Yao H; Gao Y; Zhao J; Zhang R; Xu H; Hu H; Luo Y; Yuan Y; Fu M; Zhang H; Jiang H; Wang W; Yang H; Wang J; Liang Z; Chen F
Sci China Life Sci; 2019 Feb; 62(2):215-224. PubMed ID: 30076564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
